Recommended Topic Related To:

OptiMARK

"The U.S. Food and Drug Administration announced today that injectable drugs used in total parenteral nutrition (TPN) in critical shortage will be imported into the United States and available to patients this week.

TPN is an intravenous"...

OptiMARK

Overdosage
Contraindications

OVERDOSE

Clinical consequences of overdosage with OptiMARK have not been reported. Treatment of overdose is directed toward supporting vital functions and prompt institution of symptomatic therapy. OptiMARK has been shown to be dialyzable [see CLINICAL PHARMACOLOGY].

CONTRAINDICATIONS

OptiMARK is contraindicated in patients with:

  • chronic, severe kidney disease (glomerular filtration rate, GFR < 30 mL/min/1.73m²)
  • acute kidney injury
  • known hypersensitivity reactions to gadolinium, versetamide or any of the inert ingredients

Last reviewed on RxList: 9/5/2014
This monograph has been modified to include the generic and brand name in many instances.

Overdosage
Contraindications
A A A

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Women's Health

Find out what women really need.


NIH talks about Ebola on WebMD